![Boston Energen Boston Scientific ICD with extended longevity. David Prutchi PhD www.implantable-device.com](https://www.implantable-device.com/wp-content/uploads/2012/05/Boston-Energen.jpg)
Image Credit: Boston Scientific
Boston Scientific announced today that FDA has approved revised product labeling for its INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN® ICDs and CRT-Ds to reflect increased longevity projections for these devices. The longevity projections are based on data submitted to the FDA and vary for each device dependent on the model type and settings.